FMP
Nov 05, 2025
The Mosaic Company (NYSE:MOS) is a prominent player in the fertilizers industry, specializing in the production and marketing of concentrated phosphate and potash crop nutrients. Recently, RBC Capital upgraded Mosaic's stock from "Sector Perform" to "Outperform," with the stock priced at $26.55 at the time of the upgrade. This change reflects a positive outlook on the company's future performance.
Mosaic's recent financial performance supports this optimistic view. The company reported third-quarter earnings of $1.04 per share, surpassing the Zacks Consensus Estimate of $0.98 per share. This represents a significant increase from the $0.34 per share reported in the same quarter last year, resulting in an earnings surprise of +6.12%. This strong performance may have influenced RBC Capital's decision to upgrade the stock.
In terms of revenue, Mosaic generated $3.45 billion for the quarter ending September 2025, exceeding the Zacks Consensus Estimate by 0.40%. This is a notable rise from the $2.81 billion in revenue reported a year ago. Despite this achievement, the company has only surpassed consensus revenue estimates once in the last four quarters, indicating some variability in its revenue performance.
The stock's current price of $26.55 reflects a decrease of 2.60% today, equivalent to a drop of $0.71. During the trading day, the stock reached a low of $26.24 and a high of $26.82. Over the past year, the stock has seen a high of $38.23 and a low of $22.36. With a market capitalization of approximately $8.43 billion and a trading volume of 8,021,431 shares, Mosaic remains a significant player in the market.
Investors and analysts will have the opportunity to gain further insights into Mosaic's performance and future plans during a fireside chat scheduled for November 5th. This event will be accessible via Mosaic's website and will remain available for at least one year, providing valuable information for those interested in the company's trajectory.
Grifols (NASDAQ:GRFS) is a prominent player in the medical sector, known for its focus on producing plasma-derived medic...
ACRES Commercial Realty Corp. (NYSE: ACR) is a real estate investment trust that focuses on commercial real estate finan...